Drug Development
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Clinical Trials | Drug Development | Preclinical Outsourcing
Accelerating R&D Trends
The pandemic has propelled lingering trends into the forefront and increasingly complex molecules and biologics have drug developers outsourcing more.Online Exclusives Kristin Brooks, Contract Pharma 10.20.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Samsung Biologics, Dinona Partner on Potential COVID-19 Antibody Therapy
Will collaborate for fast-track development of DNP-019, a potential COVID-19 antibody therapy.10.20.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development | Industry News
J&J Pauses All Trials Evaluating COVID-19 Vax Candidate
Temporarily pauses further dosing in all COVID-19 vaccine candidate trials to investigate an an unexplained illness.Contract Pharma Staff 10.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lilly Pauses ACTIV-3 Clinical Trial in Hospitalized COVID-19 Patients
ACTIV-3 study is evaluating the efficacy of Lilly’s neutralizing antibody in hospitalized COVID-19 patients, the most advanced stage of the disease.Contract Pharma Staff 10.16.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Rentschler Biopharma and ATUM Ink Licensing Agreement
Leap-In Transposase technology will be integrated into Rentschler’s in-house process to complement existing CLD offering.Contract Pharma Staff 10.15.20
-
Drug Development | Drug Discovery | R&D
R&D Outsourcing Trends
Highly specialized drug products and capacity needs drive increased reliance on contract service providers.Kristin Brooks, Managing Editor, Contract Pharma 10.14.20
-
cGMP Manufacture | Drug Development | Promotions & Moves
AGC Biologics Appoints New GM of Milan Site
Luca Alberici will initiate integration efforts resulting from the July 2020 acquisition of MolMed.Contract Pharma Staff 10.12.20
-
Breaking News | Collaborations & Alliances | Drug Development | R&D
Antengene, WuXi Biologics Ink Innovative Oncology R&D Alliance
Partner for the development and production of novel drugs, and to jointly promote R&D of innovative oncology therapies.Contract Pharma Staff 10.12.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lilly Submits EUA Request for COVID-19 Monotherapy
LY-CoV555 and LY-CoV016 combination therapy significantly reduced viral load at day 11, meeting the primary endpoint of the study.Contract Pharma Staff 10.07.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Eisai Enters Joint Development Agreement for COVID-19 Therapeutics
Aims to understand the mechanism of COVID-19 aggravation based on SARS-CoV-2 infection and to create drugs that prevent the aggravation of COVID-19.Contract Pharma Staff 10.07.20
-
Breaking News | Drug Development | Industry News
BMS to Acquire MyoKardia for $13.1B
Promising portfolio of pipeline candidates strengthens and extends BMS’ cardiovascular franchise.Contract Pharma Staff 10.05.20
-
Breaking News | Collaborations & Alliances | Drug Development
Diamond Pharma Services Supports GenSight Biologics
Provides EU regulatory, pharmacovigilance, quality and compliance support for LUMEVOQ.Contract Pharma Staff 10.05.20
-
Breaking News | Drug Development | Industry News | Information Technology
Dr. Reddy's Goes Paperless with ValGenesis VLMS
Digitizes validation process across multiple sites leveraging ValGenesis electronic validation lifecycle management system.Contract Pharma Staff 10.05.20
-
Drug Development
New York City is Not Dead, Our Life Sciences Sector is Thriving
Amid the COVID-19 pandemic, life sciences is booming in NYC!Sara Jane Demy, CEO & Founder, Demy-Colton 10.01.20
-
Breaking News | Drug Development
Olema Completes Series C Financing
Raises $85 million to advance clinical development of OP-1250 in breast cancer.Contract Pharma Staff 10.01.20
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
CStone, Pfizer Enter Antibody Alliance
To support CStone’s development of sugemalimab, a potential best-in-class PD-L1 antibody being developed for high-incidence cancer indications in China.Contract Pharma Staff 09.30.20
-
Breaking News | Collaborations & Alliances | Drug Development
Orgenesis to Acquire Koglio Therapeutics
Will accelerate the commercialization of Koligo’s KYSLECEL, a personalized islet cell therapy available in the U.S. for chronic and recurrent acute pancreatitisContract Pharma Staff 09.29.20
-
Breaking News | cGMP Manufacture | Drug Development | Industry News
Sobrera, Recipharm Collaborate to Advance AUD Treatment
To provide formulation development and manufacturing of SO-001, a new oral treatment for Alcohol Use Disorder.Contract Pharma Staff 09.29.20
-
Breaking News | cGMP Manufacture | Clinical Trials | Drug Development | Drug Discovery | Industry News
BioDuro, Sundia Partner as New CRDMO
Advent International investment creates services company with over 2,000 employees and 10 facilities in China and U.S.Contract Pharma Staff 09.25.20
-
Breaking News | Drug Development | Industry News | Injectables
Novosteo Inc. Adds Team Member
Jeffery Nielsen joins as director of research and development.Contract Pharma Staff 09.24.20
